31.07.2013 • News

Linde Confirms 2013 Forecast after Strong H1

After a strong first half, which saw operating profit rise nearly 14% to just under €2 billion and sales by 10.5% to €8.2 billion, German gases and engineering group Linde has confirmed its full-year 2013 forecast of generating earnings of "at least" €4 billion. From January to June, sales of the gases division improved by 14.5% to €7 billion and operating profit by 14.1% to €1.9 billion, said CEO Wolfgang Reitzle. In the engineering division, order intake was double the 2012 volume but revenues related to existing projects increased only 1.5% to €1.25 billion, and operating profit was flat at €148 million. 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.